Therapy Areas |
Pain & Inflammation |
| HOME ABOUT US THE NORDIC MARKET THERAPY AREAS PARTNERSHIP CONTACT US |
Welcome to Nordic Drugs
Since the start in 1995 we have successfully marketed pharmaceuticals of which several have achieved market leading status. Proprietary prescription and non-prescription brands as well as generics are in our portfolio. As understood from our name Sweden, Denmark (Iceland), Norway and Finland, are our home markets. Our head office is based in the most expanding part of the Nordic region i.e. Malmö, Sweden. In addition to that sales offices are located in the capitals in the other countries.
|
Nordic News |
In January, Nordic Drugs launched Ebetrex® (methotrexate) in Denmark, Sweden and Finland. Ebetrex is used by Rheumatologists for RA, PsA and JIA and by Dermatologists for Plaque Psoriasis. Nordic Drugs is now also promoting Hyalobarrier®, for effective adhesion prevention in gynae- cological surgery. Read more about Hyalobarrier. In January, Nordic Drugs launched Ebetrex® (methotrexate) in Denmark, Sweden and Finland. Ebetrex is used by Rheumatologists for RA, PsA and JIA and by Dermatologists for Plaque Psoriasis. Nordic Drugs is now also promoting Hyalobarrier®, for effective adhesion prevention in gynae- cological surgery. Read more about Hyalobarrier. |
 |
